AvKARE: Drug Recall
Recall #D-0007-2026 · 09/02/2025
Class II: Risk
Recall Details
- Recall Number
- D-0007-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AvKARE
- Status
- Ongoing
- Date Initiated
- 09/02/2025
- Location
- Pulaski, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2192 cartons
Reason for Recall
Failed Content Uniformity Specifications
Product Description
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Distribution Pattern
U.S. Nationwide
Other Recalls by AvKARE
- Class II: Risk 12/31/2025
- Class II: Risk 08/25/2025
- Class II: Risk 08/25/2025
- Class III: Low Risk 06/26/2025
- Class III: Low Risk 06/26/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.